FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
Amgen (NASDAQ: AMGN) reported Q4 EPS of $2.61, $0.32 better than the analyst estimate of $2.29. Revenue for the quarter came in at $5.54 billion versus the consensus estimate of $5.53 billion.
GUIDANCE:
Amgen sees FY2016 EPS of $10.60-$11.00, versus prior guidance of $10.35-$10.75 and... More

